ライフサイエンスコーパス: arteriosus

1 terrupted aortic arch and persistent truncus arteriosus.

2 omethacin to treat symptomatic patent ductus arteriosus.

3 ups, as was acute constriction of the ductus arteriosus.

4 ease, there is delayed closure of the ductus arteriosus.

5 pite success in closure of the patent ductus arteriosus.

6 ar pulmonary veins or a silent patent ductus arteriosus.

7 N) following prenatal ligation of the ductus arteriosus.

8 (PPHN) after prenatal ligation of the ductus arteriosus.

9 ggesting little effect on tone of the ductus arteriosus.

10 s without clinically suspected patent ductus arteriosus.

11 l heart defects including persistent truncus arteriosus.

12 tive value for the presence of patent ductus arteriosus.

13 us, with a 92% specificity for patent ductus arteriosus.

14 H) caused by prolonged closure of the ductus arteriosus.

15 chniques for coil occlusion of patent ductus arteriosus.

16 SM2 is precociously expressed in the ductus arteriosus.

17 serve a strong beta-gal signal in the ductus arteriosus.

18 ium channels, and constriction of the ductus arteriosus.

19 to the unique muscle phenotype of the ductus arteriosus.

20 ng following coil occlusion of patent ductus arteriosus.

21 of 14 preterm infants without patent ductus arteriosus.

22 sional image of the great vessels and ductus arteriosus.

23 ticopulmonary window, and persistent truncus arteriosus.

24 ntraventricular hemorrhage and patent ductus arteriosus.

25 rtery stenoses, and persistent patent ductus arteriosus.

26 bronchopulmonary dysplasia and patent ductus arteriosus.

27 ey may cause premature closure of the ductus arteriosus.

28 t ingress, with resultant persistent truncus arteriosus.

29 crotizing enterocolitis or persistent ductus arteriosus.

30 h ligand, die postnatally from patent ductus arteriosus.

31 , pulmonary stenosis, and persistent truncus arteriosus.

32 e inactivation results in persistent truncus arteriosus.

33 ar disease, tetralogy of Fallot, and truncus arteriosus.

34 velopment of smooth muscle within the ductus arteriosus.

35 l septal defects (20/47, 43%), patent ductus arteriosus (16/47, 34%), persistent left superior vena c

36 ); superior vena cava, 137 (77, 197); ductus arteriosus, 187 (109, 265); descending aorta, 252 (160,

37 atrial septal defects, 2 with patent ductus arteriosus, 2 with tetralogy of Fallot, and 1 with pulmo

38 ition of the great vessels, 3 patient ductus arteriosus, 3 partial anomalous pulmonary venous return,

39 The narrowest diameter of the ductus arteriosus (4.3 +/- 0.4 mm vs. 6.9 +/- 2.6 mm, p > 0.1)

40 53); superior vena cava, 29 (15, 43); ductus arteriosus, 41 (25, 57); descending aorta, 55 (35, 75);

41 sia or stenosis (7 patients, 11.5%), truncus arteriosus (6 patients, 10%), TGA (10 patients, 17%), an

42 l heart disease that results when the ductus arteriosus, a muscular artery, fails to remodel and clos

43 3 knockout mice an attenuation of the ductus arteriosus, a phenotype which may be indicative of outfl

44 ly increased incidence of persistent truncus arteriosus, a phenotypic change characteristic of DGS, b

45 die at mid-gestation with persistent truncus arteriosus, a severe cardiac outflow tract defect also s

46 ivo, we show that extirpation of the bulbous arteriosus-a distinct, smooth-muscle-rich tissue structu

47 than in the placebo group had patent ductus arteriosus (adjusted relative risk, 1.65; 95% CI, 1.11 t

48 ays a critical role in closure of the ductus arteriosus after birth by ensuring a reduction in local

49 ctus arteriosus and in closure of the ductus arteriosus after birth.

50 .2+/-4.9); group B, 14 patients with truncus arteriosus, aged 27 to 50 years (mean 33.7+/-7.3), follo

51 The embryos displayed persistent truncus arteriosus and abnormalities of the great vessels.

52 patterning and differentiation of the ductus arteriosus and adjacent descending aorta.

53 entiation in the vascular wall of the ductus arteriosus and adjacent descending aorta.

54 tal defects), aortic sac (persistent truncus arteriosus and aorticopulmonary window), and aortic arch

55 In other areas, such as patent ductus arteriosus and atrioventricular septal defect, the findi

56 with catheterization stenting of the ductus arteriosus and balloon atrial septostomy, especially in

57 ionship exists between patency of the ductus arteriosus and chronic lung disease and other morbiditie

58 psy and other signs, including patent ductus arteriosus and coagulopathy, while hemizygous males die

59 Patent ductus arteriosus and coarctation of aorta occurred >3 times as

60 All patients had persistent ductus arteriosus and congenital mydriasis, and variable presen

61 A third mutation causing persistent truncus arteriosus and craniofacial defects, phenotypes reminisc

62 e inflow and direction of flow in the ductus arteriosus and descending aorta were unrelated to outcom

63 tracardiac nerve trunk innervated the bulbus arteriosus and entered the arterial pole of the heart to

64 crest ablation results in persistent truncus arteriosus and failure of addition of myocardium from th

65 lG) was identified in familial patent ductus arteriosus and found to disrupt normal splicing of MYH11

66 the embryonic defects of persistent truncus arteriosus and impaired semilunar valve formation in hum

67 h in maintaining patency of the fetal ductus arteriosus and in closure of the ductus arteriosus after

68 ease, including tetralogy of Fallot, truncus arteriosus and interruption of the aortic arch.

69 a recipient neonate with persistent truncus arteriosus and irreparable truncal valve dysfunction and

70 to close after birth is termed patent ductus arteriosus and is one of the most common congenital hear

71 cle differentiation in the developing ductus arteriosus and may promote precocious expression of the

72 nterest because it also causes patent ductus arteriosus and moyamoya disease.

73 e-outlet right ventricle, persistent truncus arteriosus and right-sided aortic arches.

74 ibing an association between a patent ductus arteriosus and the development of morbidities, such as c

75 trant phenotypes included persistent truncus arteriosus and thickened valve leaflets.

76 Congenital heart defects (persistent truncus arteriosus and ventricular septal defect), hypoplastic l

77 scular defects, including persistent truncus arteriosus, and abnormal maturation of the aortic arch r

78 transverse and descending aorta, the ductus arteriosus, and across the aortic and mitral valves in i

79 cardiovascular malformation, one had truncus arteriosus, and another had a bicuspid aortic valve.

80 t cardiac lesion, for example, patent ductus arteriosus, and aortic cross-clamp time were determinant

81 transposition of the great arteries, truncus arteriosus, and interrupted aortic arch.

82 th interatrial communications, patent ductus arteriosus, and pulmonary artery stenosis requiring sten

83 ending aorta, paracoarctation aorta, truncus arteriosus, and pulmonary trunk in 86 patients were supp

84 ending aorta, paracoarctation aorta, truncus arteriosus, and pulmonary trunk were prevalent in patien

85 at angioplasty, presence of a patent ductus arteriosus, and the diameters of the aortic isthmus, dis

86 ehog (Hh) ligand is expressed in the bulbous arteriosus, and treatment with a Hh signalling antagonis

87 Neonatal ductus arteriosus aneurysm (DAA) is a rare abnormality that is

88 , 0.81; 95% CI, 0.67-0.98) and patent ductus arteriosus (AOR, 0.74; 95% CI, 0.62-0.89).

89 Rs ranging from 1.29 to 2.17), patent ductus arteriosus [aORs = 1.54, 1.63; 95% confidence intervals

90 ion, atrioventricular septal defect, truncus arteriosus, aortopulmonary septal defect, and totally an

91 Therapies designed to close the ductus arteriosus are contraindicated in some settings and shou

92 aorta, pulmonary arteries, and patent ductus arteriosus, are each amenable to transcatheter intervent

93 ch of the normoxic contraction of the ductus arteriosus at birth is related to calcium entry through

94 Closure of the ductus arteriosus at birth, essential for postnatal adaptation,

95 26+/-3 d; 147 d, term) we ligated the ductus arteriosus at surgery, and treated animals with either B

96 es to physically resemble the thicker bulbus arteriosus (BA) at the arterial pole of the heart throug

97 g stenting or stent redilation of the ductus arteriosus, balloon aortic valvuloplasty, and stenting o

98 subsequently diagnosed to have patent ductus arteriosus, based on clinical suspicion and echocardiogr

99 nts with than in those without patent ductus arteriosus because afterload is lower in the former grou

100 rioventricular septal defects, patent ductus arteriosus, bicuspid aortic valve, and coarctation of th

101 P62R, had a high prevalence of patent ductus arteriosus but had only mild abnormalities of facial fea

102 se beta-gal staining localizes to the ductus arteriosus but is absent or minimal in the pulmonary tru

103 mon after coil embolization of patent ductus arteriosus, but most close spontaneously.

104 establish and maintain patency of the ductus arteriosus by a new method of transvascular formalin inf

105 this pathway may contribute to patent ductus arteriosus by affecting the development of smooth muscle

106 y, experimental repositioning of the bulbous arteriosus by tissue recombination initiates epicardial

107 t role in control of major vessel and ductus arteriosus caliber in the rat fetus.

108 hology, osteochondrodysplasia, patent ductus arteriosus, cardiomegaly, pericardial effusion, and lymp

109 In the vast majority of infants, the ductus arteriosus closes by 3 days of life.

110 on of PGHS1-PGHS2 may explain how the ductus arteriosus closes normally at birth in mice expressing P

111 Incidence of spontaneous ductus arteriosus closure was increased, likely contributing to

112 To determine the role of PGT in ductus arteriosus closure, we used a gene-targeting strategy to

113 arteriosus vessels, VU0542270 induced ductus arteriosus constriction in a dose-dependent manner simil

114 acolepis fossils display hearts with a conus arteriosus containing at least five valve rows.

115 ral crest-derived SMCs populating the ductus arteriosus (DA) and great arteries exhibited a cell auto

116 How the ductus arteriosus (DA) closes at birth remains unclear.

117 Wild-type embryonic ductus arteriosus (DA) exhibited high levels of PRDM6, which ra

118 The ductus arteriosus (DA) is a vessel whose patency is required fo

119 Closure of the ductus arteriosus (DA) is essential for the transition from fet

120 The ductus arteriosus (DA) of newborn infants exposed in utero to i

121 Ductus arteriosus (DA) tortuosity was present in significantly

122 he fetus, PGs maintain patency of the ductus arteriosus (DA), a vascular shunt that transmits oxygena

123 is the closure and remodeling of the ductus arteriosus (DA), an arterial connection in the fetus tha

124 nge that occurs is the closure of the ductus arteriosus (DA), an arterial connection in the fetus tha

125 tal mammals depends on closure of the ductus arteriosus (DA), an arterial connection in the fetus whi

126 ate, including adverse effects on the ductus arteriosus (DA).

127 Fetal aortic and pulmonary valve; ductus arteriosus (DA); and right (RPA), left (LPA), and distal

128 to the genetic programs that underlie ductus arteriosus development and closure.

129 y diameter Z score <or=-2.5 or patent ductus arteriosus diameter <or=2 mm was 97% sensitive and 100%

130 ) with a secundum ASD, one each with truncus arteriosus, double-outlet right ventricle, L-transpositi

131 infant required ligation of a patent ductus arteriosus during ECMO.

132 ogenetic development of the aorta and ductus arteriosus during embryonic and postnatal survival.

133 cle layers of the tunica media in the ductus arteriosus exhibit positive beta-gal staining.

134 ominant trait characterized by patent ductus arteriosus, facial dysmorphism and hand anomalies.

135 as observed between PM(10) and patent ductus arteriosus (for an interquartile range increase in PM(10

136 inct AV valve, atrium, ventricle, and bulbus arteriosus form, accompanied by incremental increases in

137 7.5 per mille in 2012-2013, of patent ductus arteriosus from 1.9 per mille to 4.1 per mille, and of v

138 clearance was decreased in the patent ductus arteriosus group vs. the control group (40.02 vs. 44.73

139 a haemodynamically significant patent ductus arteriosus had a significant independent impact on %Delt

140 The infants with patent ductus arteriosus had higher values for ventricular performance

141 ranscatheter coil occlusion of patent ductus arteriosus has gained popularity, few follow-up data hav

142 revention and treatment of the patent ductus arteriosus have not documented a decrease in the inciden

143 e: Hemodynamically significant patent ductus arteriosus (hsPDA) in premature infants has been associa

144 mental defects, including persistent truncus arteriosus, hypomorphic pulmonary arteries, interrupted

145 flow tract dominated by a multi-valved conus arteriosus in basal actinopterygians, to an outflow trac

146 commanded by the non-valved, elastic, bulbus arteriosus in higher actinopterygians.

147 ription factor associated with patent ductus arteriosus in humans, was uniquely expressed in mouse du

148 rlying O2-induced constriction of the ductus arteriosus in late-gestation fetal rabbits.

149 PRRs of ASD and persistent ductus arteriosus in term infants increased with maternal BMI.

150 gic flow across the atrial septum and ductus arteriosus in the human fetus.

151 remodeling, resulting in persistent truncus arteriosus in the majority of mutant embryos.

152 05) and with medically managed patent ductus arteriosus in the white matter and deep gray matter (P =

153 Ligation of the ductus arteriosus in utero produces pulmonary hypertension and

154 tor antagonist, after ligation of the ductus arteriosus in utero.

155 iopulmonary defects, including patent ductus arteriosus, in 30 to 40% of the mice.

156 c branch defects, ASD, and persistent ductus arteriosus increase with maternal obesity severity.

157 monary dysplasia, surgery, and patent ductus arteriosus interventions (all p < 0.01/p < 0.01), surfac

158 including perinatal jaundice, patent ductus arteriosus, intraventricular hemorrhage, perinatal sepsi

159 ector mechanism for O2 sensing in the ductus arteriosus involves the coordinated action of delayed re

160 The ductus arteriosus is a specialized blood vessel containing high

161 The ductus arteriosus is a vessel that connects the pulmonary arter

162 The ductus arteriosus is a vital fetal structure allowing blood eje

163 The ductus arteriosus is an arterial vessel that shunts blood flow

164 and persists in the neonate until the ductus arteriosus is completely closed.

165 In the preterm newborn, a patent ductus arteriosus is in large part a result of the increased se

166 ether to perturb the rotation of the truncus arteriosus, leading to OFT malalignment defects includin

167 onary artery pressure (PAP) 8 d after ductus arteriosus ligation (78+/-2, HTN vs. 70+/-4 mmHg, BQ 123

168 Patent ductus arteriosus ligation among preterm neonates younger than

169 Since the first patent ductus arteriosus ligation by Robert Gross of Boston in 1938, a

170 4 premature infants undergoing patent ductus arteriosus ligation in a 1-year period at our institutio

171 sulted in fully penetrant persistent truncus arteriosus malformations.

172 In preterm infants, patency of the ductus arteriosus may represent a normal physiologic adaptation

173 associated with ligation of a patent ductus arteriosus might worsen ventricular performance in the p

174 present novel therapeutics for patent ductus arteriosus, migraine headache, and sepsis; however, the

175 reat arteries (n=14), and persistent truncus arteriosus (n=3).

176 gentamicin were administered (patent ductus arteriosus, n = 106; control, n = 216).

177 Patent ductus arteriosus occlusion can be accomplished by umbrella dep

178 ntricular septal defect, Fallot, and truncus arteriosus operations were 1.1%, 0.6%, 3.6%, 2.3%, and 2

179 f the physiologic shunting across the ductus arteriosus or atrial septum in utero (i.e., left to righ

180 Patients with persistent ductus arteriosus or congenital mydriasis with a label of 'moya

181 Impaired development of the ductus arteriosus or disruption of signaling pathways that init

182 (OR, 1.84; 95% CI, 1.74-1.94), patent ducts arteriosus (OR, 1.67; 95% CI, 1.60-1.75), intraventricul

183 a common arterial trunk ('persistent truncus arteriosus' or PTA).

184 secundum atrial septal defect, patent ductus arteriosus, or pulmonic stenosis have had infective endo

185 whether the presence and duration of ductus arteriosus patency differs between extremely preterm inf

186 presence of and a longer duration of ductus arteriosus patency were associated with the development

187 f distribution was greater for patent ductus arteriosus patients (0.61 L/kg) than for controls (0.54

188 Transcatheter closure of the patent ductus arteriosus (PDA) has increasingly been adopted in extrem

189 toned device (BD) occlusion of patent ductus arteriosus (PDA) in a large number of patients with part

190 the screening and treatment of patent ductus arteriosus (PDA) in extremely preterm infants.

191 The management of patent ductus arteriosus (PDA) in preterm infants is controversial.

192 ibuprofen may be used to treat patent ductus arteriosus (PDA) in preterm infants.

193 Nonsyndromic patent ductus arteriosus (PDA) is a common congenital heart defect (CH

194 Patent ductus arteriosus (PDA) is a common congenital heart disease th

195 nary vascular development, and patent ductus arteriosus (PDA) is a factor potentially associated with

196 Patent ductus arteriosus (PDA) is a relatively common form of congenit

197 Stenting of the patent ductus arteriosus (PDA) is an established palliative option for

198 Patent ductus arteriosus (PDA) is associated with increased mortality

199 tional studies have associated patent ductus arteriosus (PDA) ligation among preterm infants with adv

200 ale with a history of neonatal patent ductus arteriosus (PDA) ligation, left-sided choreiform movemen

201 Patent ductus arteriosus (PDA) poses a diagnostic and therapeutic dile

202 to determine the frequency of patent ductus arteriosus (PDA) reopening and the factors that may pred

203 th growth after days 1-8, with patent ductus arteriosus (PDA) showing negative associations with weig

204 A patent ductus arteriosus (PDA) shunt may be a modifiable risk factor f

205 dergo palliation with either a patent ductus arteriosus (PDA) stent or a modified Blalock-Taussig (BT

206 flow, initial palliation with patent ductus arteriosus (PDA) stent or modified Blalock-Taussig (BT)

207 closure of a moderate to large patent ductus arteriosus (PDA) using conventional techniques is challe

208 chocardiographic screening for patent ductus arteriosus (PDA) vs those who did not undergo screening.

209 The patent ductus arteriosus (PDA) was the first congenital heart lesion t

210 al septal defect (ASD) and two patent ductus arteriosus (PDA) were missed by DSCT.

211 We found that patent ductus arteriosus (PDA), a common congenital heart disease, acc

212 commonly used in infants with patent ductus arteriosus (PDA), but the benefit of these drugs is unce

213 t 16p for TAAD associated with patent ductus arteriosus (PDA).

214 ude the moderate to large size patent ductus arteriosus (PDA).

215 g indomethacin (INDO) to close patent ductus arteriosus (PDA).

216 ctation of the aorta (CoA) and patent ductus arteriosus (PDA).

217 al dilatation of the aorta and patent ductus arteriosus (PDA).

218 prior to postnatal day 3 from patent ductus arteriosus (PDA).

219 efect (ASD); device closure of patent ductus arteriosus (PDA); pulmonary valvuloplasty; aortic valvul

220 Gianturco coils to close large patent ductus arteriosus (PDAs) (> or = 3.5 mm) and describes transven

221 rage difference of 19% +/- 12 between ductus arteriosus plus isthmus flow versus descending aorta flo

222 Maintaining patency of the ductus arteriosus postnatally is necessary with many forms of c

223 diac anomalies present as persistent truncus arteriosus (PTA) and interrupted aortic arch (IAA), whic

224 iovascular malformations--persistent truncus arteriosus (PTA) and interrupted aortic arch (IAA-B).

225 Persistent truncus arteriosus (PTA) is a failure of septation of the cardia

226 development and leads to persistent truncus arteriosus (PTA), indicative of neural crest dysfunction

227 acking Smad4 in NCCs have persistent truncus arteriosus (PTA), severe OFT cushion hypoplasia, defecti

228 ng the human heart defect persistent truncus arteriosus (PTA), which trunk neural crest fails to resc

229 such as cleft palate and persistent truncus arteriosus (PTA).

230 rioventricular septal defects; patent ductus arteriosus; pulmonary stenosis; aortic stenosis; coarcta

231 and left pulmonary arteries (QP), and ductus arteriosus (QDA) were calculated in 63 normal fetuses.

232 entricular septal defect, persistent truncus arteriosus, reduced myocardial proliferation, and embryo

233 ulates epicardial regeneration after bulbous arteriosus removal, indicating that Hh signalling can su

234 malacia, chronic lung disease, patent ductus arteriosus requiring surgery, retinopathy of prematurity

235 a haemodynamically significant patent ductus arteriosus results in a deeper impairment of cerebral ox

236 Although a persistent patent ductus arteriosus results in diminished cardiac function and in

237 controversy as to whether or when the ductus arteriosus should be closed by either pharmacologic or s

238 were delivered alive from the reverse ductus arteriosus shunt group and 4 of 12 from the reverse atri

239 Reversed ductus arteriosus shunting was found with severe right heart ob

240 development, a specialized vessel the ductus arteriosus, shunts blood from the pulmonary artery to th

241 Medical treatment for patent ductus arteriosus significantly decreased over the study period

242 dified Blalock-Taussig shunt (BTS) or ductus arteriosus stent (DAS).

243 defects, patent foramen ovale, patent ductus arteriosus, stent placement for pulmonary artery stenosi

244 c arch (IAA), 34.5% of patients with truncus arteriosus (TA), and 15.9% with tetralogy of Fallot (TOF

245 ion of the great arteries (TGA), and truncus arteriosus (TA).

246 n result in persistent patency of the ductus arteriosus, the third most common congenital heart defec

247 ate (DAF-2DA) specifically labels the bulbus arteriosus throughout development from approximately 48

248 e in oxygen causes contraction of the ductus arteriosus, thus diverting blood flow to the lungs.

249 Failure of the ductus arteriosus to close after birth is termed patent ductus

250 ld be altered in neonates with patent ductus arteriosus to reflect the impact of higher volume of dis

251 was defined as tetralogy of Fallot, truncus arteriosus, transposition complexes, endocardial cushion

252 .24; 95% CI, 5.70-748.18), and patent ductus arteriosus treatment after 72 hours of life vs early or

253 notype known in humans as persistent truncus arteriosus (type A4).

254 ased, in part, on the report that the bulbus arteriosus undergoes a striated-to-smooth muscle phenoty

255 poplastic left heart syndrome, patent ductus arteriosus, valvar pulmonary stenosis, tetralogy of Fall

256 c neural crest results in persistent truncus arteriosus, ventricular dilation, and impaired ventricul

257 secundum atrial septal defect, patent ductus arteriosus, ventricular septal defect, pulmonary artery

258 ography experiments on isolated mouse ductus arteriosus vessels, VU0542270 induced ductus arteriosus

259 vascular formalin infiltration of the ductus arteriosus wall has been applied successfully to maintai

260 The ductus arteriosus wall was successfully infiltrated and dilated

261 vascular formalin infiltration of the ductus arteriosus wall.

262 regardless of whether preterm patent ductus arteriosus was included.

263 required surgical closure of a patent ductus arteriosus was lower in the budesonide group than in the

264 constriction of the great vessels and ductus arteriosus was observed with L-NIL, whereas both LPS and

265 A functionally closed ductus arteriosus was traversed with a specially designed porou

266 smoking in the household, and patent ductus arteriosus were predictive of wheezing in the previous 1

267 t left superior vena cava, and patent ductus arteriosus, were present in 32% of patients.

268 of better therapy to close the patent ductus arteriosus, which constitutes approximately 10% of all c

269 L605P was associated with persistent truncus arteriosus with interrupted aortic arch, and the Gja1W45

270 ncluding congenital mydriasis, patent ductus arteriosus with ligation, dysautonomia, low blood pressu

271 Necropsy revealed patent ductus arteriosus with normal intimal thickening but dilated ca

272 useful marker for presence of patent ductus arteriosus, with a 92% specificity for patent ductus art